Zobrazeno 1 - 10
of 143
pro vyhledávání: '"Manlio, Cipriani"'
Autor:
Alessandro Mattina, Giuseppe Maria Raffa, Maria Ausilia Giusti, Elena Conoscenti, Marco Morsolini, Alessandra Mularoni, Maria Luisa Fazzina, Daniele Di Carlo, Manlio Cipriani, Francesco Musumeci, Antonio Arcadipane, Michele Pilato, Pier Giulio Conaldi, Diego Bellavia
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Detection of high glycated hemoglobin (A1c) is associated with worse postoperative outcomes, including predisposition to develop systemic and local infectious events. Diabetes and infectious Outcomes in Cardiac Surgery (DOCS) study is a retr
Externí odkaz:
https://doaj.org/article/47c34b7fd53e44259ccefe87bcc57dda
Autor:
Alessia Gallo, Valentina Agnese, Sergio Sciacca, Cesare Scardulla, Manlio Cipriani, Michele Pilato, Jae K. Oh, Salvatore Pasta, Joseph Maalouf, Pier Giulio Conaldi, Diego Bellavia
Publikováno v:
ESC Heart Failure, Vol 11, Iss 1, Pp 155-166 (2024)
Abstract Aims MicroRNAs play a role in pathogenic mechanisms leading to heart failure. We measured a panel of 754 miRNAs in the myocardial tissue and in the serum of patients with heart failure with reduced ejection fraction due to dilatative idiopat
Externí odkaz:
https://doaj.org/article/824fa83235a44b668300e561d018f8c5
Autor:
Piero Gentile, Rosaria Cantone, Enrico Perna, Enrico Ammirati, Marisa Varrenti, Luciana D'Angelo, Alessandro Verde, Grazia Foti, Gabriella Masciocco, Andrea Garascia, Maria Frigerio, Manlio Cipriani
Publikováno v:
ESC Heart Failure, Vol 9, Iss 2, Pp 894-904 (2022)
Abstract Aims The angiotensin receptor–neprilysin inhibitor (ARNI), sacubitril/valsartan, has been shown to be effective in treatment of patients with heart failure (HF), but limited data are available in patients with advanced disease. This retros
Externí odkaz:
https://doaj.org/article/b7e93fbe7bcb4fca90fe84762d180f4a
Autor:
Francesca Cortese, Marco Matteo Ciccone, Michele Gesualdo, Massimo Iacoviello, Maria Frigerio, Manlio Cipriani, Cristina Giannattasio, Alessandro Maloberti, Paola Giordano
Publikováno v:
ESC Heart Failure, Vol 8, Iss 5, Pp 3587-3593 (2021)
Abstract Aims To evaluate endothelial function in subjects with left ventricular assist devices (LVADs), comparing them with subjects with chronic heart failure with reduced ejection fraction on the list for heart transplant (HT) and with HT patients
Externí odkaz:
https://doaj.org/article/c29880fa497b48fe9ada697c718da7dc
Autor:
Piero Gentile, Claudia Marini, Enrico Ammirati, Enrico Perna, Gianluigi Saponara, Andrea Garascia, Luciana D'Angelo, Alessandro Verde, Grazia Foti, Gabriella Masciocco, Maria Frigerio, Manlio Cipriani
Publikováno v:
ESC Heart Failure, Vol 8, Iss 5, Pp 4322-4327 (2021)
Abstract Background Patients in heart transplantation (HTx) waiting list for advanced heart failure (HF) are susceptible to acute deterioration refractory to standard HF medical therapies. Limited data are available on long‐term in‐hospital conti
Externí odkaz:
https://doaj.org/article/d2bb8de0b2a54817897b73e4eb4eb0f4
Autor:
Giuseppe Vadalà, Chiara Alaimo, Giancarlo Buccheri, Luca Di Fazio, Leandro Di Caccamo, Vincenzo Sucato, Manlio Cipriani, Alfredo Ruggero Galassi
Publikováno v:
Diagnostics, Vol 13, Iss 16, p 2709 (2023)
Cardiovascular disease (CVD) is a major cause of morbidity and mortality in patients with chronic kidney disease (CKD), especially in end-stage renal disease (ESRD) patients and during the first year after transplantation. For these reasons, and due
Externí odkaz:
https://doaj.org/article/883f650bf0754f0e8fbcb1736203eb49
Autor:
Andrea Tedeschi, Massimiliano Camilli, Umberto Ianni, Giovanni Tavecchia, Matteo Palazzini, Iside Cartella, Piero Gentile, Giuseppina Quattrocchi, Francesca Maria Spanò, Manlio Cipriani, Andrea Garascia, Enrico Ammirati
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 40, Iss , Pp 101002- (2022)
Externí odkaz:
https://doaj.org/article/63640913c87a415199d1a98751821cea
Autor:
Alessandro Maloberti, Jinwei Sun, Jessica Zannoni, Lucia Occhi, Ilaria Bassi, Saverio Fabbri, Valentina Colombo, Elena Gualini, Michela Algeri, Marisa Varrenti, Gabriella Masciocco, Enrico Perna, Fabrizio Oliva, Manlio Cipriani, Maria Frigerio, Cristina Giannattasio
Publikováno v:
Life, Vol 12, Iss 9, p 1322 (2022)
Endothelial dysfunction (ED) is frequently found in patients with heart failure (HF). Among several pharmacological agents reported to improve endothelial function, levosimendan seems to be a promising one, even though, to date, only two previously p
Externí odkaz:
https://doaj.org/article/eb1dc7cbd257414cb1b300f1bc4def47
Autor:
Leonardo De Luca, Carmine Riccio, Alessandro Navazio, Serafina Valente, Manlio Cipriani, Marco Corda, Alfredo De Nardo, Giuseppina Maura Francese, Cosimo Napoletano, Emanuele Tizzani, Loris Roncon, Pasquale Caldarola, Michele Massimo Gulizia, Domenico Gabrielli, Fabrizio Oliva, Furio Colivicchi
Publikováno v:
European Heart Journal Supplements. 25:D312-D322
Patients suffering from acute coronary syndrome (ACS) present a high risk of recurrence and new adverse cardiovascular events after hospital discharge. Elevated plasma LDL-cholesterol (LDL-C) levels have been shown to be a causal factor for the devel
Autor:
Stefania Angela Di Fusco, Alessandro Alonzo, Alberto Aimo, Andrea Matteucci, Rita Cristina Myriam Intravaia, Stefano Aquilani, Manlio Cipriani, Leonardo De Luca, Alessandro Navazio, Serafina Valente, Michele Massimo Gulizia, Domenico Gabrielli, Fabrizio Oliva, Furio Colivicchi
Publikováno v:
European Heart Journal Supplements. 25:D278-D286
In the growing therapeutic armamentarium for heart failure (HF) management, vericiguat represents an innovative therapeutic option. The biological target of this drug is different from that of other drugs for HF. Indeed, vericiguat does not inhibit n